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Background/aim: Mini/one anastomosis gastric bypass (MGB-OAGB) is a bariatric surgery procedure that has proved effective for
weight loss and the resolution of metabolic disorders. The present study evaluates the effect on postoperative outcomes of resecting the
corpus and fundus as an addition to OAGB.
Materials and methods: This retrospective study recorded and evaluated the data of 83 patients who underwent laparoscopic OAGB
due to morbid obesity (Body Mass Index-BMI ≥ 40 kg/m2) in our clinic between January 2018 and January 2020. The patients were
divided into two groups: the first group comprised patients undergoing standard OAGB (n = 49), while the second group included
those undergoing OAGB plus (OAGB with additional corpus and fundus resection) (n = 34). The patient data recorded for comparison
included demographic characteristics, comorbidities, preoperative and postoperative weight (at 6 and 12 months), body mass index
(BMI), excess weight loss% (EWL%), excess BMI loss% (EBL%), and total body weight loss% (TBWL%), hemoglobin, fasting blood
glucose (FBG), albumin and HbA1c levels.
Results: There was no statistically significant difference between the two groups with regard to age, gender or comorbidities. The
operating time, the number of cartridges used during the operation and the length of hospital stay were statistically higher in the OAGB
plus group (p = 0.039, p < 0.001, p < 0.001, respectively). No statistically significant difference was seen between the groups regarding
weight, BMI, EBL% and TBWL% preoperatively and at 6- and 12-months postsurgery. There was also no statistically significant difference
in preoperative and postoperative (at months 6 and 12) levels of hemoglobin, FBG, albumin, and HbA1c between the two groups.
Conclusion: The addition of resection of the gastric fundus and corpus to an OAGB has no impact on postoperative weight loss or
metabolic outcomes.
Key words: Morbid obesity, one anastomosis gastric bypass, bariatric surgery, weight loss, mini gastric bypass, metabolic surgery

1. Introduction
The incidence of bariatric surgery has increased in
parallel with the prevalence of obesity and its associated
comorbidities (e.g., hypertension, hyperlipidemia, and
type 2 diabetes mellitus) [1]. Nowadays, sleeve gastrectomy
(SG) followed by Roux-en-Y gastric bypass (RYGB) are
the most commonly used bariatric surgical procedures
and have long been considered as the optimal treatment
modalities. However, recently, the mini/one anastomosis
gastric bypass (OAGB-MGB) procedure, with its quick
learning curve and operation time, low risk of internal
herniation, and ability to provide intestinal stimulation
and hypo-absorption, has begun to gain popularity [2,3].
By creating a long gastric pouch and, usually, a 200-cm
jejunal omega loop, this procedure can produce effective

weight loss and metabolic control (especially of type
2 diabetes mellitus) together with low morbidity and
mortality rates [4-9].
Sleeve gastrectomy is a restrictive bariatric surgery
method, providing effective weight loss through resection
of the gastric fundus and corpus [10]. Ghrelin, a hormone
associated with hunger, is released from the oxyntic cells
that are especially abundant in the fundus; after resection,
decreasing levels of this hormone cause reduction in the
patient’s appetite [11]. On the other hand, although gastric
bypass surgery creates a narrow gastric pouch, the results
are malabsorptive rather than restrictive and metabolichormonal activity via the small bowel is its essential feature.
Roushdy et al. have previously shown in a randomized
controlled trial that the decrease in fasting ghrelin levels
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after sleeve gastrectomy is greater than that of OAGB
[12]. There is limited information on supplementing a
gastric bypass with fundus and corpus resections, as in
sleeve gastrectomy, or on the effect of such additional
procedures on postoperative outcomes. Therefore, the aim
of the present study was to reveal whether there will be
additional weight loss due to decreased ghrelin hormone
secretion by adding fundus and corpus resection to the
standard OAGB.
2. Subjects and methods
2.1. Study design
This retrospective study recorded and evaluated the
data of 83 patients who underwent laparoscopic mini/
one anastomosis gastric bypass (MGB-OAGB) to treat
morbid obesity (body mass index-BMI ≥ 40 kg/m2) at the
general surgery clinic of Health Sciences University Bursa
Higher Specialization Training and Research Hospital
between January 2018 and January 2020. The patients were
divided consecutively into two groups: the first comprised
patients undergoing standard OAGB (n = 49), while those
undergoing OAGB plus (OAGB with additional corpus
and fundus resection) made up the second group (n = 34)
(Figure 1). Detailed information about the study procedure
was provided to the patients prior to the operation, and
their written informed consent for inclusion in the study
was obtained. Ethical approval was not required for this
study, given that the manuscript is retrospective research.
2.2. Sampling
The study included patients aged 18–65 years with
a BMI ≥40 kg/m2, who experienced weight change
postoperatively at months 6 and 12, and who underwent

biochemical tests. Patients with a BMI ≤40 kg/m2, those
having an alternative bariatric procedure, patients whose
surgery needed revision and those whose preoperative
endoscopic examination had revealed severe esophagitis,
Barrett’s esophagus or gastroesophageal reflux disease,
were excluded from the study. Thirteen patients who could
not be reached during a one-year follow-up were excluded
from the study. All patients were operated on at the same
center and by the same surgical team. The morbidly obese
patients were evaluated by a dietitian and a psychologist
preoperatively and during postoperative follow-up. In
the postoperative period, the patients were placed on a
standard post-discharge diet, and were prescribed proton
pump inhibitor (PPI) therapy for the first three months.
Check-up visits were performed at 1, 3, 6, and 12 months.
An upper gastrointestinal endoscopy was performed to
obtain a biopsy from all patients preoperatively and one
year postoperatively.
The patient data recorded for comparison included
demographic
characteristics
and
comorbidities;
measurements taken preoperatively and postoperatively at
6 and 12 months of weight, body mass index (BMI), excess
weight loss% (EWL%), excess BMI loss % (EBL%), and
total body weight loss% (TBWL%), as well as hemoglobin
(g/dL), fasting blood glucose (FBG) (mmol/L), and HbA1c
(mmol/mol) levels.
2.3. Interventions
The first group received standard OAGB. Starting from
the incisura angularis (the lesser curve), a gastric pouch
was created using a 36-French bougie as a guide, and
then a loop of small bowel was run 200 cm distal to the
angle of Treitz. A 3-cm latero-lateral gastrojejunostomy

Figure 1. Schematic picture depicts forming a large and narrow gastric
pouch with bypassing part of the small bowel. OAGB; one anastomosis
gastric bypass, OAGB plus; one anastomosis gastric bypass with additional
corpus and fundus resection
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anastomosis was performed in the posterior gastric wall
using a 45-mm linear stapler. In the OAGB plus group,
the stomach was divided completely longitudinally in a
transverse fashion, starting from the incisura angularis.
The proximal part of the stomach was divided up to the
angle of HIS under the guidance of 36F gastric tube, as
in sleeve gastrectomy, and the stomach was turned into a
thin tube. As a result of division, the remaining fundus and
corpus part of the stomach were removed by resection.
The intestinal loop brought from the 200th cm from the
ligamentum of Treitz was anastomosed side-by-side
to the posterior distal end of the tube stomach (Figure
1). In both groups, a methylene blue test was made to
assess anastomotic integrity and the mesenteric defect
(Petersen’s space) was not closed. The two groups received
the same treatment during preoperative preparation and
postoperative follow-up.
2.4. Statistical analysis
A Shapiro-Wilk test was used to analyze the normality
of the preoperative and subsequent measurements.
Measurements with normal distribution were reported
as mean ± standard deviation, and those without normal
distribution were reported as median (inter quartile range:
IQR) values. The study groups were compared using the
Independent Samples t-test and Mann-Whitney U-test for
continuous variables, and Fisher’s exact test and Pearson’s
chi-square test for categorical variables. All statistical
analyses were carried out using the SPSS (IBM Corp.
Released 2012. IBM SPSS Statistics for Windows, Version
21.0. Armonk, NY: IBM Corp.) software package, and a p
value of <0.05 was considered statistically significant.
3. Results
The study included 49 patients in the OAGB group and
34 in the OAGB plus group. All surgeries were carried out
laparoscopically. Patients were assessed for demographic
characteristics, comorbidities, smoking, operating
time, number of cartridges used, morbidity and length
of hospital stay (Table 1). There was no statistically
significant difference between the two groups in terms
of age, gender or comorbidities (p > 0.05). Postoperative
morbidity developed in two patients from each of the two
groups (4.1% vs. 5.9%). In the OAGB group, one patient
experienced intraluminal bleeding, and was conservatively
treated with a blood transfusion, while a second patient
was operated on after developing ileus due to a trocar
site hernia. In the OAGB plus group, one patient needed
medical treatment for tracheal edema, and another patient
developed an anastomotic leak on postoperative day 2,
which was sutured using relaparoscopy. No postoperative
mortality was experienced in either group. The operating
time, the number of cartridges used in the operation
and the length of hospital stay were statistically higher
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in the OAGB plus group (p = 0.039, p < 0.001, p < 0.001,
respectively). At the one-year postoperative mark, all
patients underwent gastroscopy. Bile was detected in the
stomach of two (4.08%) patients in the OAGB group and
in one (2.94%) patient in the OAGB plus group while
marginal ulcers were not identified endoscopically in
either patient group. Additionally, no patients displayed
symptoms of diarrhea, vitamin deficiency, biliary or
gastroesophageal reflux disease (GERD).
A total of twenty (40.8%) patients in the OAGB group
and 18 (52.9%) in the OAGB plus group had type 2 diabetes
mellitus. At one-year postoperative, full remission was
achieved in 16 (80%) patients in the OAGB group and 10
(56%) from the OAGB plus group. Diabetes medication
was discontinued in four (20%) and eight (44%) of the
patients in the OAGB and OAGB plus groups, respectively,
and while their HbA1c levels had decreased, they were not
within normal limits, and therefore could be considered
as only in partial remission. Hypertension was observed
in 20 (40.8%) and 13 (38.2%) patients in the OAGB and
OAGB plus groups, respectively. At one year postoperative,
hypertension medication was discontinued in 16 (80%)
patients in the OAGB group and in 11 (84.6%) patients in
the OAGB plus group.
No statistically significant difference was established
between changes in weight, BMI, EBL%, EWL% and
TBWL% preoperatively and postoperatively (at 6 and 12
months) between the two groups (Table 2, Figure 2).
The patients were assessed preoperatively and
postoperatively (at 6 and 12 months) for hemoglobin, FBG,
albumin, B12 Vitamin and HbA1c levels (Table 3), and
no statistically significant difference was noted between
the groups for these parameters in the preoperative and
postoperative periods (p > 0.05). The subgroup analyses for
the diabetes mellitus patients also revealed no statistically
significant difference between the groups (p > 0.05).
4. Discussion
The mini/one anastomosis gastric bypass (MGB-OAGB)
procedure is a surgical method that can be learned
more quickly than RYGB and is known for providing a
malabsorptive effect [13]. In OAGB, a loop approximately
200 cm long is measured from the Treitz ligament, and
an anastomosis with a width varying between 2–6 cm
is made either manually or with a stapler [14]. There is,
however, no standard length for the biliopancreatic limb
[14]. In the present study, a 200-cm loop starting from
the Treitz ligament, and a 3-cm wide anastomosis using
an endoscopic stapler were standard procedures in both
groups.
According to the literature, obese patients undergoing
OAGB, record an EBL% of 72.9%–103.4%, EWL% of
65%–89% and TWL% of 36%–37.1% at the one-year
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Table 1. Demographic data, comorbidities and perioperative data of patients in the two groups.
OAGB (n = 49)

OAGB-Plus (n = 34)

P

Age

44.1 ± 10.5

44.03 ± 9.6

0.960a

Gender F/M

42/7

29/5

>0.99b

Comorbidities (+)

25 (51%)

22 (64.7%)

0.216c

T2DM (+)

20 (40.8%)

18 (52.9%)

0.276c

Smoking (+)

13 (26.5%)

8 (23.5%)

0.757c

Morbidity

2 (4.1%)

2 (5.9%)

>0.99b

Operating time (min)

113.8 ± 21.8

137.2 ± 54.8

0.039d

Number of Cartridges

6.2 ± 0.8

7.7 ± 1.1

<0.001d

Length of hospital stay (days)

5.3 ± 1.5

6.9 ± 3.1

<0.001d

One anastomosis gastric bypass: OAGB. Data presented as mean ± SD. deviation, median (Interquartile Range:
IQR) and n (%), M: Male, F: Female, T2DM: Type 2 Diabetes Mellitus
a: Independent Samples t-test, b: Fisher’s exact test, c: Pearson chi-square test, d: Mann Whitney U-Test
Table 2. Preoperative and postoperative (6 and 12 months) weight and change rates.
OAGB (n = 49)

OAGB-Plus (n = 34)

P

Preoperative
6th month
12th month

119.6 ± 15.2
81 (16.5)
74 (15.5)

118.5 ± 14.2
80 (18.5)
72.5 (14.7)

0.734a
0.236d
0.081d

BMI
(kg/m2)

Preoperative
6th month
12th month

44.3 (8.5)
31.9 ± 4.3
28.9 ± 3.9

45.1 (6.7)
30.4 ± 4.2
27.4 ± 3.9

0.229d
0.140a
0.270a

EWL%

6th month
12th month

57.0 ± 11.7
68.4 ± 11.8

61.0 ± 14.2
73.3 ± 15.3

0.165a
0.106a

6th month
12th month

69.2 ± 15.0
83.0 ± 15.6

74.4 ± 17.7
89.2 ± 18.7

0.154a
0.105a

6th month
12th month

30.5 ± 5.1
36.7 ± 5.7

31.7 ± 6.1
38.3 ± 7.3

0.323a
0.285a

Weight
(kg)

EBL%
TWL%

One anastomosis gastric bypass: OAGB. Data were presented as mean ± SD. deviation and median
(Interquartile Range: IQR)
BMI: Body mass index, EWL: Excess weight loss, EBL: Excess body mass index loss,
a: Independent Samples t-test, d: Mann-Whitney U-Test

postoperative check-up [5,6,9,14–19]. The EWL% reaches
48%–76.3% after six months [9,14,19]. Significant weight
loss is achieved after one year (EWL% >50), and the weight
loss process continues into the fifth year [20]. In the present
study, the EBL% at 6 and 12 months postoperative, was
69.2% and 83% in the OAGB group, and 74.4% and 89.2%
in the OAGB plus group; likewise, the EWL% was 57.04%
and 68.48% in the OAGB group, and 61.03% and 73.3%
in the OAGB plus group; and the TWL% was 30.5% and
36.7% in the OAGB group, compared to 31.7% and 38.3%
in the OAGB plus group. Thus, both groups of patients
were seen to lose weight effectively after OAGB, and the

overall outcomes were consistent with previous studies.
While the OAGB plus group recorded slightly better
results, there was no statistically significant difference,
although a clearer picture could possibly be achieved in
a study involving a larger number of patients and a longer
follow-up.
OAGB is reported to be an easier procedure for
surgeons to master compared to LRYGB [5]. The operating
time varies from between 27 to 210 min, in parallel with
this learning curve; the quicker procedure results from
performing only a single anastomosis in addition to no
closure of the Peterson’s space [14]. In the present study,
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Figure 2. When the groups were compared using Mann Whitney U test, there was no statistical significance
in terms of EWL % at 6th (p = 0.165) and 12th (p = 0.106) months following the operation, EWL%; Excess
Weight Loss %
Table 3. Preoperative and postoperative biochemical changes.
OAGB (n = 49)

OAGB-Plus (n = 34)

p-value

Hemoglobin (g/dL)

Preoperative
6th month
12th month

13.3 ± 1.6
12.9 ± 1.5
12.8 ± 1.2

13.5 ± 1.6
13.0 ± 1.1
12.9 ± 1.3

0.560a
0.803a
0.728a

FBG
(mmol/L)

Preoperative
6th month
12th month

104 (80)
91 (16)
86 (13.5)

105 (142.2)
85.5 (16.50)
84.5 (20.5)

0.431d
0.138d
0.650d

Albumin
(g/L)

Preoperative
6th month
12th month

4.4 ± 0.4
4.2 (0.5)
4.2 (0.6)

4.5 ± 0.2
4.3 (0.4)
4.3 (0.4)

0.440a
0.258d
0.514d

HbA1c
(mmol/mol)

Preoperative
6th month
12th month

6.2 (2.6)
5.3 (0.6)
5.3 (0.4)

6.3 (3.9)
5.4 (1.1)
5.3 (0.7)

0.203d
0.364d
0.060d

One anastomosis gastric bypass: OAGB, FBG; Fasting Blood Glucose. Data were presented as mean ± SD. deviation and
median (Interquartile Range: IQR)
a: Independent Samples t-test, d: Mann-Whitney U-Test

the operating times were 113.8 min and 137.2 min and
the number of cartridges used was 6.22 and 7.76 in the
OAGB and OAGB plus groups, respectively. Consistent
with our previous experience, our operating times were
not particularly short and, clearly, the additional resection
during the OAGB plus procedure prolonged operating
time and increased the number of cartridges used (p >
0.05).
Following OAGB, the expected perioperative morbidity
rate is in the 2.7%–9% range with a mortality rate of 0%–
0.5% [14,16]. The most common cause of morbidity is
bleeding (0.2%–2.5%) and leakage from the stapler line
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or anastomosis (0%–5%) [9,12,14,16,17,21,22]. Less often,
a trocar site or internal hernia, gastric stasis and stomal
stenosis may occur [9,16]. In the present study, both
groups had similar rates of morbidity (5.9% vs. 4.1%), and,
in line with previous studies, bleeding that could be treated
conservatively, as well as leakage that required reoperation
occurred in our patients. There was no incidence of
mortality in this series of patients.
According to the literature, the mean length of hospital
stay after OAGB varies from 1–5.4 days [14,15,18]. In the
present study, while the standard OAGB patient group was
hospitalized for a mean of 5.3 days, the mean length in

ÇAYCI et al. / Turk J Med Sci
the OAGB plus group was 6.98 days, giving a statistically
longer stay for the OAGB plus group (<0.001). Meanwhile,
our overall longer hospitalization times are consistent
with our previous experience, and most likely stem from
our free healthcare service.
After OAGB, patients are known to achieve effective
weight loss and improvement in metabolic disease
(especially in type 2 diabetes mellitus) [23,24]. The
mean rates of remission for patients with type 2 diabetes
mellitus (T2DM) and hypertension, following OAGB,
are 83.7% and 66.9%, respectively [14]. HbA1c levels are
reported to plateau after OAGB, with a mean level of 5.2
mmol/mol after two years [20]. In the present study, FBG
levels at the 6th and 12th months were 91 and 86 mmol/L,
respectively, in the OAGB group, compared to 85 and 84
mmol/L, respectively, in the OAGB plus group. HbA1c
at month 6 and month 12, were 5.3 and 5.4 mmol/mol,
respectively in the OAGB group, and 5.44 and 5.38
mmol/mol, respectively in the OAGB plus group. At
12 months after surgery, full remission was achieved
in 16 (80%) and 10 (56%) patients respectively, in the
OAGB and OAGB plus groups. Diabetes medication
was discontinued in four (20%) OAGB and eight (44%)
OAGB plus patients, and their HbA1c levels were
lowered; however, as the levels were still not within
normal limits, these cases were only considered as partial
remission. Regarding full and partial diabetes remission,
the fundus and corpus resection added to OAGB did
not produce any statistically significant difference. At
one year postoperative, 80% and 84.7% of patients in
the OAGB and OAGB plus groups, respectively, showed
remission of hypertension. The high remission rates for
hypertension and the difference in remission rates for
patients with diabetes are believed to result from the low
number of patients in each group.
The iron deficiency, anemia, has been reported to
occur in 0.64%–15% of patients after OAGB, sometimes
continuing into the fifth postop year; and is believed to
develop due to the malabsorptive nature of the OAGB
method [5,14]. In the present study, the hemoglobin levels
at months 6 and 12 were 12.9 and 12.8 in the OAGB group,
and 13.07 and 12.93 in the OAGB plus group, respectively,
indicating no significant development of anemia in
general. One possible reason for this is thought to be the
routine use of multivitamin supplements containing B12
and iron throughout the first postoperative year.

Malnutrition may be seen in 0%–3.8% of patients after
OAGB [14]. There is a lack of consensus on the optimum
length of bowel (150–300 cm) for an effective anastomosis,
although a loop longer than 200 cm is not recommended,
as it would cause malabsorption and protein-calorie
malnutrition. Also, proportioning should be made
considering the total small bowel length, if possible [8,14].
In the present study, both groups had similar levels of
albumin and no malnutrition, a probable result of the close
support of a dietitian and the use of a standard 200-cm
biliopancreatic limb length.
The bile reflux in the gastric pouch may occur in
0%–0.7% of patients, being mostly temporary and rarely
symptomatic [13,17,23,25,26]. In the present study, a
gastroscopic examination of the patients one year after
surgery identified bile in the gastric pouch in 3.1% of
patients [OAGB: n = 2 (4.08%); OAGB plus: n = 1 (2.94%)],
although they were asymptomatic. Furthermore, neither
group of patients presented with marginal ulcers, biliary
or GERD symptoms.
4.1. Limitations
Our study is limited by its single-center design, its lack
of quality of life and Ghrelin analyses, the relatively low
number of patients in each group and the short one-year
follow-up duration. In addition, the study was planned
retrospectively to avoid possible bias in the evaluation of
the data.
5. Conclusion
The number of bariatric surgical interventions performed
for the treatment of morbid obesity are increasing, and
methods are being developed aimed at achieving better
outcomes. It was found that adding gastric fundus and
corpus resections to OAGB, similar to sleeve gastrectomy
procedures, had no impact on postoperative weight loss or
metabolic resolution outcomes. On the contrary, additional
gastric resections were found to increase cost and operating
times. We believe that further studies involving a larger
number of patients and a prolonged follow-up period
are required to expand our understanding of how gastric
resections may support OAGB surgery.
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